The investment is set to expand two facilities on US soil and is part of an overarching $50 billion commitment ...
The facility is designed the ease advanced therapy development and manufacturing for partners by offering closer ...
N-1 perfusion with XCell® ATF Systems increases upstream productivity and yields while using existing bioreactor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback